KLRS
Kalaris Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 2:49:01 PM EST
1.34USD-2.190%(-0.03)14,502
Loading…
Loading…
32.26M
Previous Close
$1.37
Beta
0.52
52-Week High
$11.88 2025-12-18
52-Week Low
$1.33 2026-11-17
SMA 50
$2.41
SMA 200
$4.91
Avg. Vol 10D
131,195
Avg. Vol 30D
88,656
Avg. Vol 90D
206,938
Relative Vol
0.16
23.80M
8.64M
36.31%
366,632
5.06%
5.43
49%/51%
16.86%
14.58%
0.9400%
650,000
58
211
Jan 16, 2025 · 1-for-23 (reverse)
-43.4M
-1.91
-40.3M
-97.23
Nov 11, 2026
Nov 10, 2026
Kalaris Therapeutics Reports Q3 Net Loss ·
RTTNews
Kalaris Therapeutics, Inc. GAAP EPS of -$0.46 beats by $0.05 ·
Seeking Alpha
Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update ·
GlobeNewswire Inc.
KLRS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.66 | 2026-11-12 | -18.37% | 1.431 |
| 1M | 1.91 | 2026-10-19 | -29.06% | -1.106 |
| 3M | 4.17 | 2026-08-19 | -67.51% | -0.282 |
| 6M | 4.70 | 2026-05-19 | -71.17% | 0.348 |
| 1Y | 6.68 | 2025-11-19 | -79.72% | 0.524 |
| 2Y | 11.47 | 2025-03-19 | -88.19% | — |
KLRS Stock Summary
Kalaris Therapeutics, Inc. Common Stock (NASDAQ:KLRS) stock price today is $1.36, and today's volume is 14,500. KLRS is down 1.095% today. The 30 day average volume is 88,656. KLRS market cap is $32.26M with 23.80M shares outstanding.